Latest 10-K annual reports
NYSE
Exzeo Group, Inc. reports significant revenue and net income growth for fiscal year 2025, driven by an expanded customer base and a successful initial public offering.
NYSE
Flutter Entertainment plc reported a 17% revenue increase to $16.38 billion in fiscal 2025, driven by strategic acquisitions and U.S. growth, but posted a net loss of $407 million due to impairment and higher costs.
NYSE
DoubleVerify Holdings, Inc. announced a 14% revenue increase to $748.3 million in 2025, alongside a 10% decrease in net income to $50.7 million, while expanding its AI-powered solutions and share repurchase program.
NASDAQ
EHTH
Ehealth, INCeHealth, Inc. posted a significant increase in net income and operating income for 2025, driven by higher commission revenue and improved Medicare product lifetime values, despite a decrease in total approved members and overall estimated membership.
NYSE
CNH Industrial N.V. reported a significant drop in net income and EPS for 2025, driven by lower industry demand in agriculture and elevated tariff pressures, despite strategic investments in technology.
NASDAQ
CART
Maplebear INCInstacart (Maplebear Inc.) reported an 11% revenue increase to $3.74 billion in 2025, driven by higher orders and GTV, alongside a $60 million FTC settlement.
NASDAQ
Allegiant Travel Company reported record airline-only operating revenue of $2.5 billion in 2025, a 4.3% increase year-over-year, while advancing its strategic acquisition of Sun Country Airlines and divesting Sunseeker Resort.
NYSE
Northern Oil and Gas, Inc. reported a 1% increase in proved reserves for 2025, alongside a significant non-cash impairment charge due to declining oil prices, while increasing production and shareholder returns.
NYSE
D-Wave Quantum Inc. announced a significant revenue increase of 179% to $24.6 million in 2025, driven by system sales and professional services, yet reported a net loss of $355.1 million, a 147% increase from the prior year, as it continues heavy investment in quantum computing R&D and strategic acquisitions.
NYSE
Morgan Stanley Direct Lending Fund reports a decrease in net investment income and unrealized depreciation for 2025, alongside strategic portfolio adjustments and new joint venture formation.
NASDAQ
Xenon Pharmaceuticals Inc. continues to advance its late-stage clinical pipeline, including azetukalner for epilepsy and depression, while reporting increased net losses and R&D expenses for fiscal year 2025.
NASDAQ
RUN
Sunrun INCSunrun achieved significant revenue growth and a return to net income in 2025, driven by new system deployments and strategic solar-plus-storage offerings, despite evolving regulatory and macroeconomic challenges.
NYSE
First Horizon Corporation announced a significant increase in net income and diluted EPS for 2025, driven by lower deposit pricing, higher loan balances, and strategic technology investments.
NASDAQ
Bentley Systems, Incorporated announced robust financial results for fiscal year 2025, driven by subscription revenue growth and strategic investments in AI and digital twin technologies, alongside the appointment of James Lee as Chief Operating Officer.
NASDAQ
Nautilus Biotechnology, a development-stage life sciences company, reported a net loss of $59.0 million for 2025 as it continues to invest heavily in its Nautilus Voyager™ proteomics platform, targeting a phased commercial launch in late 2026.
NYSE
National Health Investors, Inc. (NHI) reported a 12.1% increase in total revenues to $375.6 million for the fiscal year ended December 31, 2025, driven by new acquisitions and growth in its Senior Housing Operating Portfolio (SHOP) segment.
NASDAQ
Denali Therapeutics reports increased net losses in 2025, alongside significant clinical advancements for its TransportVehicle platform and key program updates, including a PDUFA extension for tividenofusp alfa.
NASDAQ
PSNL
Personalis, INCPersonalis, Inc. reported an 18% revenue decrease in 2025, driven by reduced enterprise sales, but strengthened its cash position and secured key Medicare coverage for its cancer diagnostic tests.
NYSE
Americold Realty Trust, Inc. reported a net loss of $115.3 million for 2025, alongside strategic acquisitions and a dividend increase, despite declines in warehouse occupancy and segment revenues.
NASDAQ
CRTO
Criteo SACriteo S.A. announced a 1% revenue increase in 2025, driven by Retail Media, alongside plans to transfer its legal domicile to Luxembourg.
Diamond Hill Investment Group reports a decrease in total revenue and operating income for 2025, driven by net cash outflows in equity strategies, while progressing towards a $175.00 per share cash merger with First Eagle Investment Management.
NASDAQ
OPKO Health, Inc. reported a significantly wider net loss of $225.7 million in 2025, despite an improved operating loss and strategic divestitures aimed at streamlining its diagnostics business.
NASDAQ
Castle Biosciences reported a net loss of $24.2 million in 2025, a significant reversal from the prior year's profit, despite a 3.7% increase in total net revenues driven by non-dermatologic tests.
NASDAQ
Asure Software, Inc. announced its 2025 annual results, revealing significant revenue growth driven by its SaaS HCM solutions, alongside an increased net loss and strategic acquisitions.
NASDAQ
FRSH
Freshworks INCFreshworks Inc. reported a significant return to net income profitability in 2025, alongside strong revenue growth and a new $400 million share repurchase program.
NASDAQ
Fidus Investment Corporation's 2025 annual report highlights a growing investment portfolio, increased income, and strategic capital management, despite a slight dip in debt investment yield.
NASDAQ
Ironwood Pharmaceuticals reports a decrease in 2025 collaborative revenue for LINZESS due to pricing and inventory shifts, while advancing its apraglutide program despite a required confirmatory Phase III trial.
NASDAQ
NWPX Infrastructure, Inc. announced a 6.8% increase in net sales and a 3.5% rise in net income for 2025, alongside strategic acquisitions and robust water infrastructure market demand.
NYSE
NRDY
Nerdy INCNerdy Inc. reported a 6% decrease in 2025 revenue to $178.99 million, driven by lower Institutional revenue and a non-recurring state-funded program, despite growth in Consumer Learning Memberships and strategic AI investments.
NYSE
EPAM Systems, Inc. announced a 15.4% revenue increase to $5.46 billion in 2025, while net income and diluted EPS decreased by 16.9% and 14.3% respectively, alongside a new $1 billion share repurchase program.